Please assess the completion status of the following clinical trial:

Trial Title: Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* more than 18 years old~* Patients with solid malignant tumor treated by chemotherapy (neoadjuvant, concomittant, adjuvant or metastatic)~* Febrile neutropenia chemo-induced (fever \> 38°C, neutrophils \< 500 /microliter or nadir \< 500 /microliter)~* Patients non hospitalized at the event (when he presented febrile neutropenia)~* Informed consent signed~Exclusion Criteria:~* Thyroid medullar carcinoma~* Patient not able to understand protocol (mental retardation, psychiatric disorders, .... )

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- the predictive value of ProCalcitonin (Type: OTHER): Patients with solid tumors admitted at the emergency care presenting a febrile neutropenia due to chemotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).